This announcement is a separate document:
Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Ballal Rahul D.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.